0001415889-23-000548.txt : 20230105 0001415889-23-000548.hdr.sgml : 20230105 20230105163020 ACCESSION NUMBER: 0001415889-23-000548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROTHBLATT MARTINE A CENTRAL INDEX KEY: 0001106578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 23511741 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-01052023_040101.xml X0306 4 2023-01-03 0001082554 UNITED THERAPEUTICS Corp UTHR 0001106578 ROTHBLATT MARTINE A C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 true true false false CHAIRPERSON & CEO Common Stock 2023-01-03 4 M 0 8000 113.08 A 8130 D Common Stock 2023-01-03 4 S 0 3569 273.0371 D 4561 D Common Stock 2023-01-03 4 S 0 2253 273.6834 D 2308 D Common Stock 2023-01-03 4 S 0 2033 274.8235 D 275 D Common Stock 2023-01-03 4 S 0 145 276.4828 D 130 D Common Stock 2023-01-04 4 M 0 8000 113.08 A 8130 D Common Stock 2023-01-04 4 S 0 1612 270.8381 D 6518 D Common Stock 2023-01-04 4 S 0 3871 271.6734 D 2647 D Common Stock 2023-01-04 4 S 0 2441 272.5728 D 206 D Common Stock 2023-01-04 4 S 0 76 273.56 D 130 D Common Stock 166 I By Spouse Common Stock 644183 I By Trusts Stock Options 113.08 2023-01-03 4 M 0 8000 0 D 2013-12-31 2023-12-31 Common Stock 8000 656000 D Stock Options 113.08 2023-01-04 4 M 0 8000 0 D 2013-12-31 2023-12-31 Common Stock 8000 648000 D This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023. This transaction was executed in multiple trades at prices ranging from $272.36 to $273.34. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $273.36 to $274.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $274.395 to $275.49. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $276.26 to $276.715. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $270.165 to $271.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $271.175 to $272.065. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $272.20 to $273.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2023-01-05